chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Horrible migraine; Fever; Nausea; Muscle pains; Joint pains; This is a spontaneous report from a contactable consumer, the patient. A 27-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW01501) via an unspecified route of administration in the left arm on unknown date (at the age of 27-year-old) and second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8736) via an unspecified route of administration in the left arm on 07Apr2021 as a single dose for COVID-19 immunisation. The patient had no medical history. Concomitant medications included ibuprofen (MANUFACTURER UNKNOWN) and acetaminophen (Paracetamol) both taken from unknown date for unknown indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 04Apr2021, the patient had a horrible migraine, fever, nausea and muscle pains and joint pains since the vaccination. The clinical outcomes of horrible migraine, fever, nausea, muscle pains and joint pains were not recovered.  No follow-up attempts are possible. No further information is expected.  Amendment: This follow-up report is being submitted to amend previously reported information: added as start date and stop date for 2nd dose, added event onset date as 04Apr2021, Treatment Received updated as No for all the events.
Episodes of confusion and loss of thought continue, with no seeming trigger.; Episodes of confusion and loss of thought continue, with no seeming trigger.; Exhaustion; Extreme lethargy and loss of brain function. Barely functioned for 24hr.; Extreme lethargy and loss of brain function. Barely functioned for 24hr.; Week after shot were days where different joints would ache, very old injuries were brought back; This is a spontaneous report from a contactable consumer (patient). A 70 years old male patient received bnt162b2 (BNT162B2), dose 2 via an unspecified route of administration, administered in Arm Right on 23Mar2021 19:30 (Lot Number: ER2613) at age of 70 years old as 2nd dose, single for covid-19 immunisation.  Medical history included possible lactose intolerance developing.   The patient previously took the first dose bnt162b2 on 01Mar2021 for covid-19 immunization at age of 70 years old and took Flu vaccine for Immunization.  The patient's concomitant medications were not reported.  No trauma at injection site, no different than annual flu vaccine. Symptoms noticed after second injection next morning on 24Mar2021 07:15. Extreme lethargy and loss of brain function. Barely functioned for 24hr. Week after shot were days where different joints would ache, very old injuries were brought back in Mar2021. To date there are sudden bouts of lethargy or exhaustion. Episodes of confusion and loss of thought continue, with no seeming trigger. Talked with Doctor and was told to monitor conditions. Take ibuprofen as needed. No treatment received for events.  The outcome of event Episodes of confusion and loss of thought continue was not recovered; outcome of other events was unknown.
Extreme discomfort at injection site   swelling of hand and arm 32 hours after injection
Facial swelling, rash, itching, wheezing, flushing Solumedrol 125mg, Benadryl 50mg
acute onset sore throat, chills and achiness and light headache 4 hours after injection. S/xs abated after 12 hours except for slight residual achiness
pt received the shot and immediately felt according to him, intense pain in arm and began to loose sight. Patient then seized and went limp. We put the patient flat on the ground to protect from a fall injury and his seizing stopped. His color was very ashy and he was not responding properly to questions we asked.  In about 2 minutes, he became more coherent and began talking  and responding to our questions. Paramedics were immediately called and they arrived 30 minutes later after 3 phone calls to follow up.  Father was with patient.
Patient states they began feeling flu-like symptoms (body aches, chills, tiredness) the day after the vaccination. Patient has been taking OTC acetaminophen to help with symptoms.
Information has been received from a consumer, a 21 year old female, through the Merck Pregnancy Registry for GARDASIL, who on 05-APR-2007 was vaccinated with a first dose of GARDASIL (Lot # unknown), and on 18-SEP-2007 she was vaccinated with a second dose of GARDASIL (Lot # unknown). On 21-OCT-2007 she found out she was pregnant after the second dose. The consumer had performed two pregnancy tests, one was done on 22-OCT-2007 and then another on 08-NOV-2007. Both tests came back positive (estimated LMP 23-AUG-2007). Unspecified medical attention was sought. The consumer reported that she is 29 weeks pregnant. Follow up information has been received from a certified nurse midwife. The patient's significant past medical history was benign. The patient had one previous pregnancy which was a full term delivery. The patient's LMP was confirmed to be 19-AUG-2007 and her estimated delivery date to be 25-MAY-2008. On 04-JAN-08 the patient was started on prenatal vitamins (unspecified) for pregnancy/nutrition. The nurse midwife indicated that the following labs/diagnostics studies were performed: on an unspecified date for Hepatitis C Antibody (tested reactive); on an unspecified date recombinant immunoblot assay (RIBA) (negative); on 04-JAN-2008 alpha-fetoprotein (AFP) (negative) and on 10-JAN-2008 an ultrasound for anatomay (WNL, confirmed dates). On 10-MAR-2008 the patient had a 24 hour urine test and liver function tests which were within normal levels. On 10-MAR-2008, the patient also had a hematocrit of 30, which was done because of anemia. The reporter noted that on 24-MAR-2008, at 31 weeks gestation, the patient fell and hit her abdomen. Labs and electronic fetal monitoring were within normal at that time. On1 5-APR-2008 the patient was started on ED Cyte F for the anemia. No product quality complaint was involved. On 23-MAY-2008, at 39 5/7 weeks from the LMP, the patient underwent primary caesarean section for multiple variable fetal heart decelerations shown on electronic fetal monitoring, and delivered a full-term healthy, normal baby with no congenital anomalies. The baby's weight: 8lbs 12 ozs; length; 20 1/4 inches; Apgar score: 8/9. Upon internal review, the patient's caesarean section due to multiple fetal heart decelerations was considered to be an other important medical event. Additional information is not expected.
Same day post vax, the pt developed injection site pain which radiated throughout her arm. On 10/20/99, she developed an area of redness and warmth at the injection site which was a little larger than a half dollar. On 10/21/99, the redness and pain began to subside, however, the site of vaccination began to itch. On 10/23/99, she experienced dizziness/light-headedness and nausea. Her physician treated her with Zantac and ibuprofen. As of 10/27/99, her light-headedness persisted and worsened upon lying down. The nausea also persisted but was getting better.
First day couldn't move arm at all - very numb. Got better each day, by 3rd day can move but still in discomfort. Patient has been icing it & taking pain killers.
Case number PHEH2015US020449 is an initial combined spontaneous report received from a pharmacist on 09 Oct 2015 with a follow up information received on Oct 2015 with a follow up information received on 19 Oct 2015. This report refers to a 65 year old female patient. Past medical history and concomitant medications were not reported. The patient was vaccinated with FLUCELVAX (batch number: 161211, expiry date: May 2015) pre-filled syringe (PFS) at a dose of 0.5 ml intramuscularly on 02 Oct 2015. It was reported that the administered vaccine was expired. The case was reported non-serious. No adverse events were reported following the maladministration. The pharmacist stated that the patient was doing well and would be re-vaccinated. Following an internal review on 28 Oct 2015, it was found that the case PHEH2015US020230 was a duplicate PHEH2015US020449. Hence all the information from case PHEH20105US020230 was merged into PHEH2015US020449 and the case PHEH2015US020230 would be deactivated. Merged information included reporter's comment in the narrative (patient was doing well and would be re-vaccinated).
Patients received an invalid COVID Bi-valent booster vaccine, expiration date exceeded 10-week thaw expiration. Patient had no adverse reaction.  Per Pfizer and the CDC this is a storage handling error (temp excursion) and a repeat dose is recommended immediately no minimum interval. The CDC also recommends waiting 8 weeks for an additional immunization due to increased risk of myocarditis in certain age groups.  Patient will be called and notified by clinic leadership
7 days after the shot, I developed rash and itchiness around the injection site  It?s still there today 2/13/2021 ,  so far 2 days  I put some steroid cream to ease itchiness  I have not yet contacted my doctor
Reaction was to 4th vaccine: Moderna.  Acute symptoms occured 1 PM 4/12/22 although there were subtle changes in increasing tinnitus and sleep interference several days prior that -obvious only retrospectively. Severe vertigo, nystagmus, tinnitus, light and sound sensitivy began at 1 PM and were severe by 2:30 PM. Lay in bathroom floor vomiting and unable to move or open eyes for 6.5 hours.  Husband is physican and was out of town. Tried to administer care when he got home but too debilitated by then.  EMT called and arrived about 1.5 hours later. Taken to  ER at about 7:30 PM.  Not seen until about 9:45 PM by ER physicain. Had negative MRI (with gadolinium) for mild divergence insufficiency few months prior, so not repeated.  Diganosed as preriphereal vestibular vertigo, sent home at 5:30 AM 4/13/22 and referred to ENT.  Saw Dr. , ENT on 4/18.  GIven hearing test with nothing remarkable showin and aboth ears functioning similarly.  He confirmed relationship between vaccine and my reaction.  My neuro-ophthalmologist (seen in past for mild divergence insufficiency) went over everything withme  and confirmed the association and referred me to VAERS.  Note: my husband is Trained CT surgeon -retired and I am a trained hospital administrator with a laboratory background -retired.  I made the initial association when I could think straight again, read and suspected relationship  (not much is published), knowing that the virus itself could damage hearing function and ear.  Pushed husband, he read and was convinced and that's when we knew what we were dealing with.  Dr.  prescribed 5-day course of 20 mg Predinsone (I am very thin thus dosage).  On third dose currently.  Not sure any effect.  May have been more effective if delivered by ER but no one connected the dots or even asked about vaccine. They just don't know about this side effect and this is a hospitla!  Get the word out!    Remaining symptoms as of today 4/21/2022: Vertigo is 85% recovered.  Eye issues (probably lingering nystagmus) recovered about 75%.  Tenor of high pitched tinnitus: very little improvement.
Feel like I have the flu, feel like I have a fever, chills (no fever), feel dizzy.
Patient and mother called 24 hours after vaccination reporting temperature 101 F that started 7pm and continued.  Friday 07/21/2006 temperature 103 degrees also complained of headache, muscle pain, and spasm.  Seen by pediatrician 07/21/2006 fever continued until 07/23/2006.
Information has been received from a physician concerning a 11 year old female who was vaccinated with the first dose of GARDASIL and had an anaphylactic reaction. The patient was reported to be recovered. The physician does not plan to continue to vaccination series. Additional information has been requested.
RIGHT ARM PAIN AND SORENESS X 1 WEEK LATER S/P VACCINATION, WHICH RADIATES TO HAND AND FINGERS, AND RIGHT UPPER BACK. MD AT URGENT CARE PRESCRIBED OTC MOTRIN.
4 hours after administration (1/8/21) I had nausea. The following day (1/9/21) I had a mild fever, body aches, headache, and was fatigued. These symptoms lasted until about 7pm until I took Tylenol. Once I took Tylenol I felt almost immediately better.
Nurse received the Moderna vaccine after receiving the Johnson and Johnson vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of INTERCHANGE OF VACCINE PRODUCTS (Nurse received the Moderna vaccine after receiving the Johnson and Johnson vaccine) in a 30-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Sulfonamide allergy (Sulfa).    On 29-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Jul-2021, the patient experienced INTERCHANGE OF VACCINE PRODUCTS (Nurse received the Moderna vaccine after receiving the Johnson and Johnson vaccine). At the time of the report, INTERCHANGE OF VACCINE PRODUCTS (Nurse received the Moderna vaccine after receiving the Johnson and Johnson vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication reported.  No treatment details reported.  Patient received the dose of the Johnson and Johnson vaccine on 07JUL2021 (Historical vaccine).   Most recent FOLLOW-UP information incorporated above includes: On 20-Aug-2021: additional information received updated patient details, relevant history, product information
Pfizer-BioNTech COVID-19 Vaccine EUA  5 hours after receiving vaccine vertigo-like symptoms developed. I also experienced standard side-effects(nausea, vomiting, fever, aches, chills, headache which subsided after 24 hours. I'm still extremely dizzy and disoriented.
Case number PHHY2016US059733 is an initial literature report received on 28 Apr 2016. The author described about a case of antibody-verified anti-N-methyl-D-aspartate (anti-NMDA) receptor encephalitis in a neonate following influenza vaccination. This report refers to a 7 month old female patient. She was previously healthy. She was vaccinated with a booster dose of influenza vaccine (manufacturer and batch number: not reported) during her first influenza season (vaccination date was not reported). Within 48 hours of vaccination, she presented with acute onset of altered mental status, decreased activity, roving eye movements and opisthotonic posturing. She was initially diagnosed with acute demyelinating encephalomyelitis (ADEM) and treated with a short burst of corticosteroids followed by a taper. Symptoms subjectively improved during steroid therapy, but did not persist, prompting further diagnostic evaluations. Anti-NMDA receptor encephalitis was confirmed by cerebrospinal fluid antibody titer 68 days after onset of symptoms. Treatment was then undertaken with serial courses of intravenous immunoglobulin (IVIG) and rituximab. The patient's hospital course was protracted and she required utilization of intensive care unit resources due to aspiration risk, surgical placement of nutritional and vascular access devices and paroxysmal autonomic hyperactivity (PAH). Minimal improvement in her neurologic exam was observed at time of hospital discharge and might be due to delayed start of treatment as well as the cumulative effect of unrecognized seizures early in her illness course. The author stated that this case described the youngest patient with ant-NMDA receptor encephalitis yet reported and the first to suggest correlation with recent influenza vaccination. The author concluded the article stating that as higher likelihood of neurologic recovery was associated with early initiation of treatment, providers were encouraged to consider autoimmune neurologic disorders like anti-NMDA receptor encephalitis when mental status abnormalities and developmental regression persist, regardless of patient's age.
Dec 11th 2pm - Mild pain at the injection site 4:45pm - Stood up, experienced dizziness & spots in vision, fainted (Was caught and put on couch) , injection site pain increased to severe pain (patient said it feels like her muscle is torn), Nausea, hot flashes.
Temp 105 onset 1 wk after MMR vaccine; Pt had episode of shaking, LOC, ?apnea/vs seizure observed 48 hrs in hosp, Recovered completely.
Approximately 1 1/2 hours after vax given, antibiotic injection for infection - URI, OM, throat and nose. Seen at local ER. Antibiotics given to clear up bacterial infection. No permenant damage.
Arm pain within 15 minutes of injection. Unable to sleep because of pain. Fever the next day along with light-headed, no appetite and injection site swelling. Area was hot and hard to the touch. Area remained swollen for 5 days.
Asthma-like condition; Arthralgia aggravated; This spontaneous case was reported by a consumer and describes the occurrence of ASTHMA (Asthma-like condition) and ARTHRALGIA (Arthralgia aggravated) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) solution for injection for Rheumatoid arthritis and Ulcerative colitis.    The patient's past medical history included COVID-19 in December 2020. Concurrent medical conditions included Rheumatoid arthritis and Ulcerative colitis.   On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient started ADALIMUMAB (HUMIRA) (Subcutaneous) UNK, Citrate free. On an unknown date, the patient experienced ASTHMA (Asthma-like condition) and ARTHRALGIA (Arthralgia aggravated). At the time of the report, ASTHMA (Asthma-like condition) outcome was unknown and ARTHRALGIA (Arthralgia aggravated) had not resolved.            No concomitant medication were reported. On unknown dates patient experienced more joint pain three to four days before injection was due and had asthma like issues.  No treatment medication were reported. This case was identified as part of a retrospective clean-up activity where certain emails received in the Moderna
Mild discomfort and redness at site for 1st 4 days then on 1/6/15 whole arm hurting, upper back on left side, discomfort, dull pain, numbing, losing sensation in arm and having difficulty gripping/grasping items w/left hand.
The expiration date was incorrectly noted when the last extension was granted by agency. Vaccine expiration was noted as 9/28 when correct date should have been 9/21
Pts left knee started getting stiff and sore six days post vax. Treated with ice and kept elevated. The next day the knee was more swollen. Unable to touch toe to floor or walk using left leg. Pt went to ER.
15 minutes after vaccination began with tinnitus, dizziness, nausea. Felt extremely ill for next 11 days. October 26 right leg and arm collapsed and I fell. Went to ER. Checked for stroke or other illness. Nothing found and sent home. One week later right leg went numb, became sicker and almost passed out. Went to ER and admitted for observation. After many tests, nothing found and sent home. Three days later left leg became numb. Got even sicker with blury vision, hot flashes, chills and migraines - no fever. Spent two months using walker. Have since had tinnitus, vestibular problems, leg muscle weakness, sore feet, red toes and toenails have stopped growing, foot cramps, extreme fatigue, foggy head, and have just
Fever 104-105, lethargy, and vesicular rash. Fever/lethargy, began 1/1/15, and rash 1/2/15.
Night of 8.25.21 and continuing: Severe: body aches, joint pain, fatigue Moderate: headache, fever and throat mucus
Subject in pneumococcal vaccine trial, with severe COPD, was hospitalized with a COPD exacerbation. Vaccination took place 01.27.2009. According to the physician the relationship is None. We would be happy to fax you the Study SAE report.
lifeless; inappropriate age; This case was reported by a consumer via call center representative and described the occurrence of feeling lifeless in a adult male patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix at an unknown dose. On an unknown date, unknown after receiving Shingrix, the patient experienced feeling lifeless and inappropriate age at vaccine administration. On an unknown date, the outcome of the feeling lifeless and inappropriate age at vaccine administration were unknown.   It was unknown if the reporter considered the feeling lifeless to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient received Shingrix in his 40s which led to inappropriate age at vaccine administration and experienced a feeling of being lifeless. No further information was reported. This is 1 of 4 linked case reported by same reporter.
Blood Pressure 130/88, resp - non labored, chest burning, dry throat, skin cool, arms dry, face and legs sweaty, runny nose. Refused to go to hospital.
Light head ache.; sore arm; This is a spontaneous report from a contactable consumer, the patient. A 53-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: ER8733) in the left arm on 26Mar2021(at the age of 53-years-old) at 19:15 as a single dose for COVID-19 immunisation. The patient had no medical history. The patient had no known allergies to medications, food or other products. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination the patient had not tested for COVID-19. On 26Mar2021 at 21:00, the patient experienced, light head ache and sore arm. Therapeutic measures were not taken as a result of headache and sore arm. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The The clinical outcome of the event light headache and sore arm was recovered on 27Mar2021.    No follow-up attempts are needed. No further information is expected.
localized pain on the 3rd day, in the armpits on the side that received the vaccine; 2 days of fever; This is a spontaneous report from a contactable consumer (patient).  A 13-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: RX#6123158) via an unspecified route of administration in right arm on 18Jul2021 14:00 (at the age of 13-year-old) as dose 2, single for covid-19 immunization. Patient was not pregnant at the time of vaccination. Patient was known allergic to penicillins. There were no concomitant medications. The patient previously received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: RX6121432) via an unspecified route of administration in right arm on 27Jun2021 14:00 (at the age of 12-year-old) as dose 1, single for covid-19 immunization. Patient had not been diagnosed with COVID-19 prior to vaccination and had not been tested since the vaccination. Patient had not received any other vaccine in four weeks. On an unspecified date in Jul2021, the patient experienced 2 days of fever and localized pain on the 3rd day (20Jul2021) in the armpits on the side where the vaccine was received. Therapeutic measures were taken as a result of the event 2 days of fever. Patient was not received other medications in two weeks. The clinical outcome of the events was unknown.   Follow-up attempts are completed. No further information is expected.
Soft tissue mass and circulation problems in left arm, inside of elbow, in the same arm of injection.